| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.15B | 54.34B | 57.42B | 53.86B | 31.82B | 24.39B |
| Gross Profit | 24.73B | 23.81B | 26.69B | 24.98B | 14.51B | 10.14B |
| EBITDA | 11.85B | 11.51B | 13.19B | 13.67B | 5.75B | 3.07B |
| Net Income | 6.27B | 5.75B | 7.73B | 8.46B | 2.93B | 1.23B |
Balance Sheet | ||||||
| Total Assets | 57.72B | 59.28B | 57.29B | 59.31B | 48.33B | 41.52B |
| Cash, Cash Equivalents and Short-Term Investments | 17.45B | 19.59B | 16.96B | 20.43B | 17.42B | 16.58B |
| Total Debt | 0.00 | 0.00 | 0.00 | 464.00K | 2.00B | 2.00B |
| Total Liabilities | 11.02B | 9.61B | 12.00B | 18.59B | 14.93B | 10.38B |
| Stockholders Equity | 46.70B | 49.67B | 45.29B | 40.72B | 33.40B | 31.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.22B | 2.08B | 6.30B | 1.94B | 2.28B |
| Operating Cash Flow | 0.00 | 5.95B | 7.67B | 8.43B | 2.98B | 3.22B |
| Investing Cash Flow | 0.00 | -2.71B | -7.85B | -1.73B | -1.98B | -564.73M |
| Financing Cash Flow | 0.00 | -1.61B | -3.30B | -3.18B | -666.28M | -1.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥98.90B | 4.62 | ― | 4.76% | 1.01% | 79.22% | |
77 Outperform | ¥31.49B | 6.12 | ― | 3.79% | -5.36% | -24.55% | |
70 Outperform | ¥57.57B | 7.43 | ― | 2.03% | -18.06% | 64.88% | |
64 Neutral | ¥786.24B | -8.91 | 6.07% | 3.69% | 3.69% | -66.27% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
53 Neutral | ¥169.78B | -61.67 | -6.21% | 1.61% | -1.34% | -107.63% |